pharma news

News

Boehringer bags FDA okay for new pulmonary fibrosis drug

Boehringer's successor to blockbuster IPF therapy Ofev has been approved by the FDA as Jascayd, but will the new drug be a commercial success?

News

After FDA exit, Peter Marks pops up at Lilly

The ousted former director of CBER, Peter Marks, has joined Eli Lilly as head of molecular discovery and infectious disease research.

News

MSD advances on a broad front with TL1A drug tulisokibart

MSD's confidence in its anti-TL1A drug tulisokibart in inflammatory diseases is made apparent by a decision to start trials in three new indications.

News

AZ chalks up another positive trial for hypertension drug

AstraZeneca's baxdrostat has hit the mark in another phase 3 trial in resistant hypertension, keeping it on track for filing later this year.

News

Ignota's co-founder and chief executive, Sam Windsor

Ignota vacuums up Kronos Bio's drug programmes

Ignota Labs of the UK has acquired all of the clinical-stage assets in Kronos Bio's pipeline, after the US firm ceased operations earlier this year.

News

Acting CDC director says MMR jabs should be split

The acting director of the CDC, Jim O’Neill, has been sharply criticised after saying the MMR vaccine should be separated into three individual shots.

Boehringer bags FDA okay for new pulmonary fibrosis drug

After FDA exit, Peter Marks pops up at Lilly

MSD advances on a broad front with TL1A drug tulisokibart

AZ chalks up another positive trial for hypertension drug

Ignota vacuums up Kronos Bio's drug programmes

Acting CDC director says MMR jabs should be split

EU clears first drug therapy for rare disease cALD

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks